Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 33.83 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 9.30 | Oscillator | Buy |
| Williams %R (14) | -90.28 | Oscillator | Buy |
| MACD (12, 26, 9) | -0.39 (Hist -1.06) | Oscillator | Strong Sell |
| Average Directional Index (14) | 23.62 (+DI 11.3 / -DI 29.9) | Trend | Sell |
| EMA 20 | 54.59 | MA | Strong Sell |
| SMA 20 | 55.10 | MA | Strong Sell |
| EMA 50 | 52.54 | MA | Strong Sell |
| SMA 50 | 53.63 | MA | Strong Sell |
| SMA 200 | 37.78 | MA | Strong Buy |
Current price $49.31
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Sep 2, 26 | HC Wainwright & Co. | maintain | Buy | Buy |
| Aug 25, 26 | UBS | maintain | Neutral | Neutral |
| Aug 18, 26 | Goldman Sachs | maintain | Neutral | Neutral |
| Aug 12, 26 | TD Cowen | maintain | Hold | Hold |
| Jul 30, 26 | Goldman Sachs | maintain | Neutral | Neutral |
| Mar 30, 26 | HC Wainwright & Co. | maintain | Buy | Buy |
| Mar 12, 26 | Goldman Sachs | maintain | Buy | Buy |
| Jan 30, 26 | Goldman Sachs | maintain | Buy | Buy |
| Nov 10, 25 | HC Wainwright & Co. | maintain | Buy | Buy |
Stock news · updated daily
Here is how Calumet, Inc. (CLMT) and ConocoPhillips (COP) have performed compared to their sector so far this year.
INDIANAPOLIS, Oct. 15, 2026 /PRNewswire/ -- Calumet, Inc. (NASDAQ: CLMT) (the "Company" or "Calumet") today announced that its wholly owned subsidiaries, Calumet Specialty Products Partners, L.P. (the "Partnership") and Calumet Finance Corp. (together with the Partnership, the "Issuers"), have given notice for redemption of $150 million of the outstanding 9.75% Senior Notes due 2028 (CUSIP Nos.
Calumet Specialty Products (CLMT) is poised to deliver a potentially stunning Q3 EBITDA of $300–$325 million, driven by strong crack spreads and operational improvements. Current valuation appears rich, with technical indicators overbought and EBITDA run rates well above normalized levels, suggesting a correction may be imminent. I am lowering my rating from strong buy to buy, recommending investors wait until after earnings and the planned Shreveport shutdown before adding shares.
REPYY, TGT and CLMT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on October 13, 2026.
ROKU, FET, CLMT, FTI and SHEL stand out after a screen identified stocks with efficiency ratios above their industry averages.
CVX, SNDK and CLMT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on October 6th, 2026.
INDIANAPOLIS, Oct. 6, 2026 /PRNewswire/ -- Calumet, Inc. (NASDAQ: CLMT) (the "Company," "Calumet," "we," "our" or "us"), announced today that it plans to report results for the Third Quarter 2026 on November 6, 2026. A conference call to discuss the financial and operational results is scheduled for November 6th at 9:00 AM ET.
SNDK, CLMT, CVX, HRB and GSBD have been added to the Zacks Rank #1 (Strong Buy) List on October 6th, 2026.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 7, 2026 | 0.07 | -1.09 | Miss -1717.0% | $1.45B |
| May 8, 2026 | -0.57 | -3.64 | Miss -538.6% | $1.03B |
| Feb 27, 2026 | -0.67 | -0.43 | Beat 35.8% | $1.04B |
| Nov 7, 2025 | -0.35 | -3.61 | Miss -930.9% | $1.08B |
| Aug 8, 2025 | -0.44 | -1.70 | Miss -286.4% | $1.03B |
| May 9, 2025 | -0.41 | -1.87 | Miss -356.1% | $993.9M |
FY2025 · 10-K disclosure
TTM vs. 5-year historical average (annual ratios)
| Metric | CLMT | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | -31.8x | -8.2x · sector 16.6x | Discount |
| Forward P/E (FY26E) | -23.8x | EPS est. -2.07 | Discount |
| Price / Book | -3.8x | -2.6x | Elevated |
| Price / Sales | 0.9x | 0.4x | Elevated |
| EV / EBITDA | -237.5x | -378.2x | Discount |
| Return on equity | 15.2% | — | Healthy |
| Gross margin | 6.6% | 6.9% | In line |
| Debt / Equity | -1.99 | -3.84 | Conservative |
| Piotroski / Altman Z | 5/9 | Z 1.07 | Distress |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Oct 19, 26 | Lunin David | officer: EVP - CFO | M-Exempt | 20,000 | — |
Discounted cash flow model
| Oct 19, 26 |
| Lunin David |
| officer: EVP - CFO |
| F-InKind |
| 7,954 |
| — |
| Oct 19, 26 | Lunin David | officer: EVP - CFO | M-Exempt | 20,000 | — |
| Sep 25, 26 | Borgmann Louis Todd | officer: CHIEF EXECUTIVE OFFICER | M-Exempt | 107,428 | — |
| Sep 25, 26 | Borgmann Louis Todd | officer: CHIEF EXECUTIVE OFFICER | F-InKind | 46,901 | — |
| Sep 25, 26 | Borgmann Louis Todd | officer: CHIEF EXECUTIVE OFFICER | M-Exempt | 107,428 | — |
| Sep 25, 26 | Fleming Bruce A | officer: EVP - MONTANA RENEWABLES | M-Exempt | 107,428 | — |
| Sep 25, 26 | Fleming Bruce A | officer: EVP - MONTANA RENEWABLES | F-InKind | 42,190 | — |
| 4 | Sep 28, 2026 | 2026-09-28 16:35:23 | View |
| 8-K | Sep 15, 2026 | 2026-09-14 17:46:04 | View |
| 8-K | Sep 1, 2026 | 2026-09-01 16:20:21 | View |
| 4 | Aug 21, 2026 | 2026-08-21 16:06:51 | View |
| 4 | Aug 21, 2026 | 2026-08-21 16:06:15 | View |
| 4 | Aug 21, 2026 | 2026-08-21 16:05:28 | View |
Proxy statement (DEF 14A) disclosures